These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30635291)

  • 1. Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
    Shin SH; Jeong DY; Lee KS; Cho JH; Choi YS; Lee K; Um SW; Kim H; Jeong BH
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software.
    Casal RF; Sepesi B; Sagar AS; Tschirren J; Chen M; Li L; Sunny J; Williams J; Grosu HB; Eapen GA; Jimenez CA; Ost DE
    Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
    Decaluwé H; Moons J; Fieuws S; De Wever W; Deroose C; Stanzi A; Depypere L; Nackaerts K; Coolen J; Lambrecht M; Verbeken E; De Ruysscher D; Vansteenkiste J; Van Raemdonck D; De Leyn P; Dooms C;
    Eur J Cardiothorac Surg; 2018 Jul; 54(1):134-140. PubMed ID: 29447330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
    Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
    Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitions of Central Tumors in Radiologically Node-Negative, Early-Stage Lung Cancer for Preoperative Mediastinal Lymph Node Staging: A Dual-Institution, Multireader Study.
    Kim H; Choi H; Lee KH; Cho S; Park CM; Kim YT; Goo JM
    Chest; 2022 May; 161(5):1393-1406. PubMed ID: 34785237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Exactly Is a Centrally Located Lung Tumor? Results of an Online Survey.
    Casal RF; Vial MR; Miller R; Mudambi L; Grosu HB; Eapen GA; Jimenez CA; Morice RC; Cornwell L; Ost D
    Ann Am Thorac Soc; 2017 Jan; 14(1):118-123. PubMed ID: 27854541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
    Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
    Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study.
    Vial MR; O'Connell OJ; Grosu HB; Hernandez M; Noor L; Casal RF; Stewart J; Sarkiss M; Jimenez CA; Rice D; Mehran R; Ost DE; Eapen GA
    Respirology; 2018 Jan; 23(1):76-81. PubMed ID: 28857362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
    Gómez-Caro A; Garcia S; Reguart N; Arguis P; Sanchez M; Gimferrer JM; Marrades R; Lomeña F
    Eur J Cardiothorac Surg; 2010 May; 37(5):1168-74. PubMed ID: 20116273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.